| Patient | Sigmund Freud |
|---|---|
| Date of birth | 1952-05-06 |
| Identifiers | MRN HR-ET005-SYN; SSN (made up) 000-05-8403 |
| Document date | 2026-07-13 |
| Author | Anton Reinholt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week review: cutting down, setting a quit date, pain and weight. [S]
Mr. Freud returns six weeks after intake. He smokes about six cigars a day and has chosen a quit date one week from today. The quitline has called him three times. The nausea stopped once he took varenicline after food, and the dreams are milder. The relined obturator seals better: liquids leak into his nose only now and then, and his speech is clearer. The sore spot had healed by the two-week check at the prosthodontics clinic. Dr. Vasquez-Lindqvist took impressions for the new obturator last week. The speech-language therapy sessions have not started because the first appointment was cancelled. His pain is 4 of 10 and he is eating more. [S]
| Element | Detail |
|---|---|
| Cigars | About six a day; quit date one week from today |
| Varenicline | 1 mg twice daily after food; no nausea; milder dreams |
| Quitline | Three calls |
| Pain | 4 of 10 |
| Weight | 58.9 kg |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Eating more; no fever |
| Ears, nose, mouth, and throat | Positive | Occasional nasal leakage of liquids; sore spot healed; no bleeding or lump |
| Respiratory | Positive | Morning cough, less than before |
| Psychiatric | Negative | Mood steady; some irritability on low-cigar days |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days | One tablet daily for three days, then twice daily for four days, after food | Oral route | 2026-06-01 to 2026-06-08 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks | One tablet twice daily after food | Oral route | 2026-06-08 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site | Two tablets three times daily | Oral route | 2026-06-01 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-13 | Body height | 172 | cm | S |
| 2026-07-13 | Body weight | 58.9 | kg | S |
| 2026-07-13 | Body mass index (BMI) [Ratio] | 19.9 | kg/m2 | S |
| 2026-07-13 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-07-13 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-07-13 | Heart rate | 76 | /min | S |
| 2026-07-13 | Respiratory rate | 16 | /min | S |
| 2026-07-13 | Body temperature | 36.6 | Cel | S |
| 2026-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-13 | Pain severity in the past week - 0-10 numeric rating [Reported] | 4 | {score} | S |
Vital signs recorded on 2026-07-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 134/80, pulse 76; weight 58.9 kg |
| Mouth | With the obturator out: ulcer at the defect margin healed; no mass, induration or white or red patch |
| Neck | No lymph nodes felt |
| Speech | Mild hypernasality with the relined obturator |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smoking | active | confirmed | F17.290 | S — Synthetic modern coding; person-first language; not a claim about his real diagnosis. |
| Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillance | active | confirmed | Z85.818 | S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic. |
| Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorly | active | confirmed | Z90.09 | S — Synthetic modern coding anchored to his documented obturator. |
| Hypernasal speech and nasal leakage of liquids from a poorly sealing obturator | active | confirmed | R49.21 | S — Synthetic finding; resolved when the new obturator was fitted. |
| Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubs | active | confirmed | G89.29 | S — Synthetic modern coding anchored to his documented constant mouth pain. |
| Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smoking | active | confirmed | E78.5 | S — Synthetic finding on the intake lipid panel. |
| Weight loss of 4 kg in six months from painful chewing and leakage, with a low albumin | active | confirmed | R63.4 | S — Synthetic finding; resolved as weight and albumin recovered. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Tobacco use (cigars a day), readiness and quit date | Every visit | Completed today | About six cigars a day; quit date in one week |
| Medication safety | Varenicline adherence and side effects (nausea, sleep, dreams, mood) | Every visit; at least 12 weeks, extended to 24 weeks or more | Completed today | No nausea after food; milder dreams; mood steady |
| Medication safety | Combination nicotine replacement (patch and lozenge) | From the quit date for at least 8 to 12 weeks | Ordered | 21 mg patch and 4 mg lozenge from the quit date |
| Self-management | Behavioral support (quitline and clinic sessions) | Weekly calls around the quit date, then every two to four weeks | Completed today | Three quitline calls since enrollment; weekly calls around the quit date |
| Examination | Head and neck surveillance examination (mouth, defect and neck) | Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visit | Completed today | Ulcer healed; no mass, induration or white or red patch; neck clear; yearly surgeon's examination booked for next month |
| Imaging | Head and neck imaging | Only for symptoms or signs more than five years after treatment | Not indicated | No symptoms or signs of recurrence |
| Examination | Second primary cancer counseling and symptom review | Every visit | Completed today | No hoarseness, trouble swallowing, cough with blood or blood in the urine; second primary risk explained again |
| Examination | Obturator fit, seal and hygiene | Every visit | Completed today | Relined obturator seals better; impressions for the new obturator taken last week |
| Referral | Speech and swallowing (hypernasality, nasal leakage) | Every visit; speech-language therapy as needed | Deferred | Speech-language therapy has not started: the first appointment was cancelled by the clinic and not rebooked. No harm so far: speech is clearer with the reline. Corrective action: rebooked within two weeks, with a reminder call |
| Self-management | Dental care (high-fluoride toothpaste, cleaning every three months) | Daily toothpaste; cleaning every three months | Completed today | Using high-fluoride toothpaste nightly; the two root caries found at the consultation were filled by his dentist |
| Examination | Weight and nutrition | Every visit | Completed today | 58.9 kg, up 0.5 kg |
| Survey | Pain score and function | Every visit | Completed today | 4 of 10 |
| Medication safety | Acetaminophen daily dose (no more than 3,000 mg) | Every visit | Completed today | 3,000 mg a day |
| Medication safety | Opioids | Avoid long-term opioids | Not indicated | Not needed |
Goal progress:
Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022)
Follow-up: Quit date in one week, with quitline calls. Speech-language therapy within two weeks. Head and neck surgeon's yearly examination next month. Twelve-week review in six weeks, when the new obturator is fitted. Next scheduled visit 2026-08-24: twelve-week review: five weeks without smoking, the new obturator and survivorship surveillance. [S]